STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental Disorder

Clinical trial pipeline · Data from ClinicalTrials.gov

See which STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental Disorder trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Active — Not RecruitingEarly Phase 1

NCT04937062

Phenylbutyrate for Monogenetic Developmental and Epileptic Encephalopathy

This study is to evaluate the use of glycerol phenylbutyrate for monogenetic developmental epileptic encephalopathies (DEEs). DEEs are characterized by epilepsy…

United States50 participantsStarted 2021-03-01

Treatment: Glycerol Phenylbutyrate 1100 MG/ML [Ravicti]